Skip to main content
. 2017 Jan 25;40(6):383–389. doi: 10.1002/clc.22674

Table 2.

Comparison of patients with acute procedural change versus those without any acute procedural change

Variable Acute Change, n = 8 No Acute Change, n = 19 P Value, Significance <0.05
Age, y 65.9 ± 6.4 63.8 ± 9.9 0.60
Male sex 8 (100%) 14 (73.7%) 0.28
BMI, kg/m2 31.1 ± 6.1 30.2 ± 5.8 0.67
CHA2DS2VASC 2.1 ± 1.0 1.9 ± 1.6 0.36
Hypertension 5 (62.5%) 13 (68.4%) 1.00
Coronary artery disease 3 (37.5%) 2 (10.5%) 0.14
Prior CVA 2 (25%) 1 (5.3%) 0.20
OSA 2 (25%) 5 (26.3%) 1.00
AF duration, y 4.0 ± 4.4 4.6 ± 3.8 0.75
AF on presentation 3 (37.5%) 15 (83.3%) 0.06
SR on presentation 5 (62.5%) 3 (15.8%) 0.03
LVEF, % 54.1 ± 5.6 52.5 ± 8.3 0.64
LA size, cm 4.2 ± 0.6 4.8 ± 0.8 0.06
Redo procedure 3 (37.5%) 11 (57.9%) 0.42
Fluoroscopy time, min 62.3 ± 11.0 58.9 ± 11.4 0.49
RF time, min 47.1 ± 13.2 43.6 ± 15.2 0.60
Total no. of rotors 3.8 ± 1.7 2.5 ± 1.0 0.02
Rotors in RA 1 ± 1.2 1.1 ± 0.8 0.89
Rotors in LA 2.8 ± 1.2 1.5 ± 1.0 0.01
Early recurrence (in blanking period) 1 (12.5%) 8 (42.1%) 0.20

Abbreviations: AF, atrial fibrillation; BMI, body mass index; CHA2DS2VASC, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age 65–74 years, sex category; CVA, cerebrovascular accident; LA, left atrium; LVEF, left ventricular ejection fraction; OSA, obstructive sleep apnea; RA, right atrium; RF, radiofrequency; SR, sinus rhythm.